Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-24 @ 3:01 PM
NCT ID:
NCT03509259
Eligibility Criteria:
Inclusion Criteria:
* If the doctor has been diagnosed with asthma and one or more of the following criteria is met;
1. FEV1 increased more than 12% \& 200 mL after 10-20 minutes of inhalation of short-acting bronchodilator (200-400 mg salbutamol)
2. Positive bronchial provocation tests (methacholine, mannitol, exercise, aspirin, etc.)
3. FEV1 Increased more than 12% \& 200 mL from baseline FEV1 after anti-inflammatory treatment for 4 weeks or longer.
Exclusion Criteria:
* Those who were already diagnosed and treated for coronary artery diseases.
* Those with other structural lung diseases such as Tuberculosis destroyed lung and interstitial lung diseases
* Those who are unable to conduct a test or questionnaire due to severe systemic illness, or cognitive dysfunction.
* Those who are participating in other clinical trial using IND(investigational new drug) or finished other clinical trial within 30 days.
* Those who refuse to participate in the study or withdraw the consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT03509259
Study Brief:
Protocol Section:
NCT03509259